Literature DB >> 30071943

Anti-Ro antibodies and complete heart block in adults with Sjögren's syndrome.

Kerry Jobling1, Hanaa Rajabally1, Wan-Fai Ng2.   

Abstract

There are emerging case reports worldwide of complete heart block in adults who test positive for anti-Ro antibodies and the underlying primary Sjögren's syndrome (pSS). The association between fetal/congenital cardiac abnormalities and transplacental transfer of anti-Ro antibodies is well established; there is, however, an ongoing debate about the underlying mechanism of activity of these antibodies in the cardiac tissue. In the past, maternal cardiac tissue was believed to be resistant to these pathogenic effects. This case highlights the need to change our understanding of how these antibodies cause adverse arrhythmogenic cardiac effects in adults. We present the case of a 44-year-old female with pSS and positive anti-Ro autoantibodies, who was diagnosed with autoimmune-induced complete heart block after presenting with dizziness and palpitations. She required insertion of a permanent cardiac pacemaker and has made a full recovery. Although the arrhythmogenic effects are rare, it may be that cardiac conduction in adults is not as resistant to anti-Ro antibodies as proposed.

Entities:  

Year:  2018        PMID: 30071943      PMCID: PMC6116846          DOI: 10.5152/eurjrheum.2018.18019

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  9 in total

1.  Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages.

Authors:  M E Miranda-Carús; A D Askanase; R M Clancy; F Di Donato; T M Chou; M R Libera; E K Chan; J P Buyon
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 2.  United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease.

Authors:  Wan-Fai Ng; Simon J Bowman; Bridget Griffiths
Journal:  Rheumatology (Oxford)       Date:  2010-08-06       Impact factor: 7.580

3.  Anti-Ro antibodies and reversible atrioventricular block.

Authors:  Irene Santos-Pardo; Melania Martínez-Morillo; Roger Villuendas; Antoni Bayes-Genis
Journal:  N Engl J Med       Date:  2013-06-13       Impact factor: 91.245

4.  Complete heart block caused by primary Sjögren's syndrome and hypopituitarism.

Authors:  D C Baumgart; H Gerl; T Dörner
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

Review 5.  Complete atrioventricular block in adult Sjögren's syndrome with anti-Ro autoantibody.

Authors:  Myung Jun Sung; Sung-Hoon Park; Seong-Kyu Kim; Young-Soo Lee; Chul-Yeon Park; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

6.  Direct inhibition of expressed cardiac l- and t-type calcium channels by igg from mothers whose children have congenital heart block.

Authors:  G Q Xiao; K Hu; M Boutjdir
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

Review 7.  Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses.

Authors:  P E Lazzerini; P L Capecchi; F Laghi-Pasini
Journal:  Scand J Immunol       Date:  2010-09       Impact factor: 3.487

8.  Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies.

Authors:  E Alexander; J P Buyon; T T Provost; T Guarnieri
Journal:  Arthritis Rheum       Date:  1992-02

9.  The high incidence of anti-Ro/SSA and anti-p200 antibodies in female patients with connective tissue diseases confirms the importance of screening for congenital heart block-associated autoantibodies during pregnancy.

Authors:  E Cozzani; Arianna Fay Agnoletti; F Pappalardo; I Schiavetti; A Torino; A Parodi
Journal:  Arch Dermatol Res       Date:  2016-02-01       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.